跳至主要内容
临床试验/KCT0002900
KCT0002900已完成未知

A randomized comparison of clinical outcomes between everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stent in long coronary lesions

Yonsei University Health System, Severance Hospital0 个研究点目标入组 341 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
341

研究概览

简要总结

At 12 months, the primary endpoint events occurred in 2 patients (1.2%) in the BVS group and in 4 patients (2.4%) in the EES group (hazard ratio [HR]=0.49, 95% confidence interval [CI]=0.09-2.67, P=0.398).

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 85(Year)(—)
性别
All

入选标准

  • Age 19-85 years
  • Patients with ischemic heart disease requiring PCI
  • Significant coronary de novo lesion (stenosis >50% by quantitative angiographic analysis) requiring stent =28 mm in length based on angiographic estimation
  • Reference vessel diameter of 2.5 to 3.75 mm by operator assessment

排除标准

  • Acute myocardial infarction within 48 hours with unstable hemodynamics requiring pharmacologic or mechanical support
  • Complex coronary morphology including left main disease and bifurcation lesion requiring two-stent technique
  • Contraindication or hypersensitivity to anti-platelet agents or contrast media
  • Treated with any metallic stent or BVS within 3 months at other vessel
  • Cardiogenic shock
  • Left ventricular ejection fraction <40%
  • Pregnant women or women with potential childbearing
  • Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator
  • Inability to understand or read the informed content

研究者

相似试验